跳至主要内容
临床试验/JPRN-UMIN000019966
JPRN-UMIN000019966已完成2 期

Efficacy and safety of valproic acid in patients with postviral olfactory dysfunction - Valproic acid treatment of olfactory dysfunction

Shiga university of Medical Science0 个研究点目标入组 15 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion Criteria concerning Diagnosis 1)Patients taking Carbapenem,Barbituric acid,phenytoin, Carbamazepine, ethosuximide, amitriptyline, clobazam, lamotrigine, salicylic acid, Benzodiazepine, warfarin, erythromycin, cimetidine, clonazepam) 2) Patients having a history of serious drug allergies 3) Patients with severe depression, suicidal thinking or suicide attempt or past history of any of these diseases 4) Patients with liver dysfunction 5) Patients with renal dysfunction 6) Female patients having fertility 7) Patients with urea cycle abnormality 8) Patients with past history of an encephalopathy or a coma caused by unknown 9) Patients having a family member with urea cycle abnormality or who experience infant death 10) Patients with subjective olfactory loss before onset of postviral olfactory dysfunction 11) Patients who are otherwise judged unfit as a subject for this trial by a principal investigator or investigators participating in this trial

研究者

相似试验